Paris-based Cure51 raises €15M in seed funding https://t.co/oJBgySNwVK https://t.co/PHm05b5qKC
Welcome @Cure51 to the Sofinnova family! Our Digital Medicine strategy led the €15M seed funding round for Cure51. They're driving a paradigm shift in cancer research by focusing on what drives survival, rather than the disease. Congratulations! https://t.co/R3xnv5NDLe https://t.co/3gRQZQJJGY
Cure51 raises a €15M Seed round aiming to crack the code on cancer survival: https://t.co/lO9soou4oV by TechCrunch #infosec #cybersecurity #technology #news


Health tech startup The Carevoice secures $10 million in Series B funding, defying the funding slowdown trend. Cure51, a cancer research company, also raises €15 million in a Seed round to focus on improving cancer survival rates. Sofinnova leads the funding for Cure51, emphasizing a shift towards survival-focused research. Paris-based Cure51 receives the seed funding.